ShangPharma Corp

Most Recent

  • uploads///
    Fund Managers

    Highlights of Magnetar Capital’s 4Q14 Position Decreases

    Magnetar Capital’s portfolio remained highly concentrated in energy stocks, which represented over 60% of its 4Q14 US long portfolio value.

    By Santiago Solari
  • Financials

    Paulson’s bet turns sour as AbbVie reconsiders its Shire bid

    News reports in August noted that Renaissance Technologies LLC, Jana Partners, David Einhorn’s Greenlight Capital, Dan Loeb’s Third Point LLC, and Paulson & Co. posted losses in July.

    By Samantha Nielson
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.